Determination of Ghrelin Immunoreactivity in Kidney Tissues of Diabetic Rats

dc.contributor.authorKuloglu, Tuncay
dc.contributor.authorDabak, Durrin Ozlem
dc.date.accessioned2026-08-12T17:45:55Z
dc.date.issued2009
dc.departmentFırat Üniversitesi
dc.description.abstractBackgrounds/Aims. Ghrelin, a recently discovered hormone, is released largely from stomach and might affect insulin secretion and glucose metabolism. The aim of this study was to determine the immunohistochemical localization of ghrelin in streptozotocin- induced diabetic rat kidneys. Methods. Fifty-four adult male Wistar rats were used in this study. All rats were divided into nine groups according to three time points of the study (2, 4, and 6 weeks) as control group, control group given 0.1 M phosphatecitrate, and diabetic group given 50 mg/kg streptozotocin intraperitoneally. The rats in all groups were decapitated at the end of 2, 4, and 6 weeks of the study. The kidneys of the rats were removed, and tissue samples were processed by using routine paraffin techniques. The samples were immunohistochemically stained using avidin-biotin-peroxidase method for ghrelin immunoreactivity. Results. There were no differences of ghrelin immunoreactivity between the control groups. Ghrelin immunoreactivity was observed in both distal tubulus and collecting ducts in the diabetic groups, while it was detected only in distal tubules of the control groups. The intensity of ghrelin immunoreactivity was increased at 4 and 6 weeks of the study in the diabetic groups. Conclusion. Increased ghrelin immunoreactivity in the diabetic rat kidney tissues suggests that ghrelin may contribute to the pathophysiological mechanism of diabetic nephropathy.
dc.description.sponsorshipFirat University Scientific Research Projects Management Unit (FUBAP) [1309]
dc.description.sponsorshipThis research was supported by Firat University Scientific Research Projects Management Unit (FUBAP) project number 1309.
dc.identifier.doi10.1080/08860220903050405
dc.identifier.endpage566
dc.identifier.issn0886-022X
dc.identifier.issn1525-6049
dc.identifier.issue7
dc.identifier.orcid0000-0001-7210-6873
dc.identifier.orcid0000-0001-9874-3838
dc.identifier.pmid19839851
dc.identifier.scopus2-s2.0-72649098390
dc.identifier.scopusqualityQ2
dc.identifier.startpage562
dc.identifier.urihttps://doi.org/10.1080/08860220903050405
dc.identifier.urihttps://hdl.handle.net/11508/60866
dc.identifier.volume31
dc.identifier.wosWOS:000271014900006
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofRenal Failure
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectdiabetes mellitus
dc.subjectimmunohistochemistry
dc.subjectkidney
dc.subjectghrelin
dc.subjectrats
dc.titleDetermination of Ghrelin Immunoreactivity in Kidney Tissues of Diabetic Rats
dc.typeArticle

Dosyalar